Response to: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection

Fertil Steril. 2024 Feb;121(2):358. doi: 10.1016/j.fertnstert.2023.09.008. Epub 2023 Sep 19.

Authors

Ana Rita Batista¹, Juan-Enrique Schwarze¹, Monica Lispi²

Affiliations

¹ Global Medical Affairs Fertility, R&D Biopharma, Merck KGaA, Darmstadt, Germany.
² Global Medical Affairs Fertility, R&D Biopharma, Merck KGaA, Darmstadt, Germany; International PhD School in Clinical and Experimental Medicine (CEM), University of Modena and Reggio Emilia, Modena, Italy.

PMID: 37734649
DOI: 10.1016/j.fertnstert.2023.09.008

No abstract available

Publication types

Letter
Comment

MeSH terms

Fertilization in Vitro
Follicle Stimulating Hormone
Humans
Male
Menotropins*
Ovulation Induction
Randomized Controlled Trials as Topic
Recombinant Proteins
Semen
Sperm Injections, Intracytoplasmic*

Substances

Follicle Stimulating Hormone
Menotropins
Recombinant Proteins